Andrew P Demidowich1,2, Kristine Batty1, Teresa Love3, Sam Sokolinsky4, Lisa Grubb5, Catherine Miller6, Larry Raymond3, Jeanette Nazarian1, M Shafeeq Ahmed5, Leo Rotello7, Mihail Zilbermint2,7. 1. Johns Hopkins Community Physicians at Howard County General Hospital (HCGH), Division of Hospital Medicine, Johns Hopkins Medicine, Columbia, MD, USA. 2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. 3. Rehab Services, Diabetes Management & The Center for Wound Healing, HCGH, Johns Hopkins Medicine, Columbia, MD, USA. 4. JHHS Quality and Clinical Analytics, Johns Hopkins Hospital, Johns Hopkins Medicine, Baltimore, MD, USA. 5. Johns Hopkins Armstrong Institute at HCGH, Johns Hopkins Medicine, Columbia, MD, USA. 6. Division of Nursing - Critical Care, HCGH, Johns Hopkins Medicine, Columbia, MD, USA. 7. Johns Hopkins Community Physicians at Suburban Hospital, Division of Hospital Medicine, Johns Hopkins Medicine, Bethesda, MD, USA.
Abstract
BACKGROUND: Community hospitals account for over 84% of all hospitals and over 94% of hospital admissions in the United States. In academic settings, implementation of an Inpatient Diabetes Management Service (IDMS) model of care has been shown to reduce rates of hyper- and hypoglycemia, hospital length of stay (LOS), and associated hospital costs. However, few studies to date have evaluated the implementation of a dedicated IDMS in a community hospital setting. METHODS: This retrospective study examined the effects of changing the model of inpatient diabetes consultations from a local, private endocrine practice to a full-time endocrine hospitalist on glycemic control, LOS, and 30-day readmission rates in a 267-bed community hospital. RESULTS: Overall diabetes patient days for the hospital were similar pre- and post-intervention (20,191 vs 20,262); however, the volume of patients seen by IDMS increased significantly after changing models. Rates of hyperglycemia decreased both among patients seen by IDMS (53.8% to 42.5%, P < .0001) and those not consulted on by IDMS (33.2% to 29.9%; P < .0001). When examined over time, rates of hypoglycemia steadily decreased in the 24 months after dedicated IDMS initiation (P = .02); no such time effect was seen prior to IDMS (P = .34). LOS and 30DRR were not significantly different between IDMS models. CONCLUSIONS: Implementation of an endocrine hospitalist-based IDMS at a community hospital was associated with significantly decreased hyperglycemia, while avoiding concurrent increases in hypoglycemia. Further studies are needed to investigate whether these effects are associated with improvements in clinical outcomes, patient or staff satisfaction scores, or total cost of care.
BACKGROUND: Community hospitals account for over 84% of all hospitals and over 94% of hospital admissions in the United States. In academic settings, implementation of an Inpatient Diabetes Management Service (IDMS) model of care has been shown to reduce rates of hyper- and hypoglycemia, hospital length of stay (LOS), and associated hospital costs. However, few studies to date have evaluated the implementation of a dedicated IDMS in a community hospital setting. METHODS: This retrospective study examined the effects of changing the model of inpatient diabetes consultations from a local, private endocrine practice to a full-time endocrine hospitalist on glycemic control, LOS, and 30-day readmission rates in a 267-bed community hospital. RESULTS: Overall diabetes patient days for the hospital were similar pre- and post-intervention (20,191 vs 20,262); however, the volume of patients seen by IDMS increased significantly after changing models. Rates of hyperglycemia decreased both among patients seen by IDMS (53.8% to 42.5%, P < .0001) and those not consulted on by IDMS (33.2% to 29.9%; P < .0001). When examined over time, rates of hypoglycemia steadily decreased in the 24 months after dedicated IDMS initiation (P = .02); no such time effect was seen prior to IDMS (P = .34). LOS and 30DRR were not significantly different between IDMS models. CONCLUSIONS: Implementation of an endocrine hospitalist-based IDMS at a community hospital was associated with significantly decreased hyperglycemia, while avoiding concurrent increases in hypoglycemia. Further studies are needed to investigate whether these effects are associated with improvements in clinical outcomes, patient or staff satisfaction scores, or total cost of care.
Entities:
Keywords:
diabetes; hospitalist; hyperglycemia; inpatient; length of stay; readmissions
Authors: Suqing Li; Sylvia Roschkov; Abdullah Alkhodair; Blair J O'Neill; Constance L Chik; Ross T Tsuyuki; Gabor T Gyenes Journal: Can J Diabetes Date: 2016-09-19 Impact factor: 4.190
Authors: Mikhail Kosiborod; Silvio E Inzucchi; Harlan M Krumholz; Lan Xiao; Philip G Jones; Suzanne Fiske; Frederick A Masoudi; Steven P Marso; John A Spertus Journal: Circulation Date: 2008-02-11 Impact factor: 29.690
Authors: Samantha R Mandel; Susan Langan; Nestoras Nicolas Mathioudakis; Aniket R Sidhaye; Holly Bashura; Jun Y Bie; Periwinkle Mackay; Cynthia Tucker; Andrew P Demidowich; William F Simonds; Smita Jha; Ifechukwude Ebenuwa; Melinda Kantsiper; Eric E Howell; Patricia Wachter; Sherita Hill Golden; Mihail Zilbermint Journal: J Community Hosp Intern Med Perspect Date: 2019-04-12
Authors: Jingtong Huang; Andrea M Yeung; Kevin T Nguyen; Nicole Y Xu; Jean-Charles Preiser; Robert J Rushakoff; Jane Jeffrie Seley; Guillermo E Umpierrez; Amisha Wallia; Andjela T Drincic; Roma Gianchandani; M Cecilia Lansang; Umesh Masharani; Nestoras Mathioudakis; Francisco J Pasquel; Signe Schmidt; Viral N Shah; Elias K Spanakis; Andreas Stuhr; Gerlies M Treiber; David C Klonoff Journal: J Diabetes Sci Technol Date: 2022-07-29
Authors: Carter Shelton; Andrew P Demidowich; Mahsa Motevalli; Sam Sokolinsky; Periwinkle MacKay; Cynthia Tucker; Cora Abundo; Eileen Peters; Roliette Gooding; Margaret Hackett; Joyce Wedler; Lee Ann Alexander; Luvenia Barry; Mary Flynn; Patricia Rios; Constance Lulu Fulda; Michelle F Young; Barbara Kahl; Eileen Pummer; Nestoras N Mathioudakis; Aniket Sidhaye; Eric E Howell; Leo Rotello; Mihail Zilbermint Journal: J Diabetes Sci Technol Date: 2021-04-21